Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

PREMIER Biosoft Announce Successful Delivery of OligoArchitect™ Online v4.0 to Sigma-Aldrich

Published: Thursday, September 05, 2013
Last Updated: Thursday, September 05, 2013
Bookmark and Share
As a part of its contract software development services, PREMIER Biosoft has delivered OligoArchitect™ Online v4.0 to Sigma Life Science.

PREMIER Biosoft, as a part of its contract software development services, has delivered OligoArchitect™ Online v4.0 to Sigma Life Science, the innovative biological products and services research business of Sigma-Aldrich. Sigma-Aldrich, with operations in over 40 countries, is a life science and high technology company. Its chemical and biochemical products are used in scientific research and as key components in high technology manufacturing.

This release of version 4.0  of OligoArchitect™ Online offers added LNA® base substitution in Dual-Labeled Probe, Molecular Beacon and LightCycler® Probe design modules. 

"By introducing LNA design capabilities into OligoArchitect Online, a wide range of customers can now gain access to this chemistry. PREMIER Biosoft is now our trusted vendor, after demonstrating exemplary delivery of former versions of OligoArchitect and OligoEvaluator™," said Tom Russell, Product Manager at Sigma Life Science.

"After the successful launch of version 3.0 of OligoArchitect, Sigma further raised the bar by requesting support for LNA design. Our goal is to offer Sigma customers the best possible user experience and robust design algorithms," said Arun Apte, CEO, PREMIER Biosoft.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Dr. Vladimir Shulaev Joins PREMIER Biosoft Scientific Advisory Board
Dr. Shulaev joins SAB to further the development of software solutions for metabolomics and lipidomics research.
Saturday, September 19, 2015
PREMIER Biosoft Announces Collaboration with University of Utah
Formal collaboration to advance metabolomics and lipidomics research.
Friday, August 07, 2015
PREMIER Biosoft Wins CIOReview's "Company of the Year" Award
"Company of the Year" award for the year 2014 in the life science category.
Thursday, February 19, 2015
PREMIER Biosoft Launches SimMet for Analysis of MS Metabolite data
SimMet is a high throughput, intuitive informatics tool for qualitative and quantitative analysis of mass spectrometry metabolite data.
Tuesday, May 27, 2014
PREMIER Biosoft and JEOL Enter Agreement
The co-marketing agreement aims to advance research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology.
Thursday, June 06, 2013
PREMIER Biosoft Acquires ProteoIQ
Company adds strength to its mass spectrometry product portfolio with the acquisition of ProteoIQ from NuSep, Australia.
Tuesday, March 12, 2013
Premier Biosoft and MRC-Holland Form Alliance
The alliance will help MLPA® users design custom oligos for genes that do not have kits available.
Monday, October 30, 2006
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos